109 reports of this reaction
1.7% of all COLESTIPOL HYDROCHLORIDE reports
#11 most reported adverse reaction
DIZZINESS is the #11 most commonly reported adverse reaction for COLESTIPOL HYDROCHLORIDE, manufactured by Pharmacia & Upjohn Company LLC. There are 109 FDA adverse event reports linking COLESTIPOL HYDROCHLORIDE to DIZZINESS. This represents approximately 1.7% of all 6,329 adverse event reports for this drug.
Patients taking COLESTIPOL HYDROCHLORIDE who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for COLESTIPOL HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for COLESTIPOL HYDROCHLORIDE:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 109 FDA reports for COLESTIPOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 1.7% of all adverse event reports for COLESTIPOL HYDROCHLORIDE, making it a notable side effect.
If you experience dizziness while taking COLESTIPOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.